JBM (Healthcare) Ltd (HKSE:02161) Share Price

Company Profile

Business description
JBM (Healthcare) Ltd markets and distributes healthcare products. The company's operating segment includes Branded medicines; Proprietary Chinese medicines and Health and wellness products. It generates maximum revenue from the Proprietary Chinese medicines segment. The Proprietary Chinese medicines segment develops, manufactures, and distributes registered Chinese medicines composed solely of any Chinese herbal medicines specified in the Chinese Medicine Ordinance, or any materials of herbal, animal, or mineral origin customarily or widely used by the Chinese. Geographically, it derives a majority of its revenue from Hong Kong.
Contact
108 Wai Yip Street
Units 808-811, 8 floor, C-Bons International Centre
Kwun Tong, Kowloon
Hong Kong
HKG
T: +852 22672182
https://www.jbmhealthcare.com.hk
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
412

Recommended

The stocks of these high-quality companies with large market capitalizations look undervalued today.

Margaret Giles | 02 February 2026

Prices of these shares exceed our Fair Value Estimate by more than double.

Morningstar | 02 February 2026

Compounders tend to deliver steadier, more durable profit growth across full cycles, making them better suited for long-term investors.

Robert M. Almeida | 02 February 2026

Index	Last price	Change	% Change
All Ordinaries	9,068.80	42.20	-0.46%
CAC 40	8,187.24	60.71	0.75%
DAX 40	24,798.53	259.72	1.06%
Dow JONES (US)	49,245.55	353.08	0.72%
FTSE 100	10,314.85	91.31	0.89%
HKSE	26,775.57	611.54	-2.23%
NASDAQ	23,609.62	147.80	0.63%
Nikkei 225	52,655.18	667.67	-1.25%
NZX 50 Index	13,412.44	10.74	-0.08%
S&P 500	6,971.07	32.04	0.46%
S&P/ASX 200	8,778.60	42.50	-0.48%
SSE Composite Index	4,015.75	102.20	-2.48%